PKF 115–584 has been originally described as a small-molecule inhibitor of β-catenin/TCF/LEF complexes blocking the transcriptional activity of β-catenin in the colon cancer cell line HCT116, while β-catenin expression is not affected [25]. Here, HNF4A is linked to malignant colon neoplasm.